Matthew Roden, Aktis Oncology CEO (MPM Capital)

Are ra­dio­phar­ma­ceu­ti­cals ready for the main­stream? No­var­tis, Bris­tol My­ers Squibb bet yes on MP­M's plat­form take

Bri­an Good­man, Patrick Baeuer­le and Todd Fo­ley weren’t ex­act­ly look­ing to start a ra­dio­phar­ma­ceu­ti­cals com­pa­ny.

Rather, the team at MPM Cap­i­tal — which had been known …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.